Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study
Nephrology (Carlton)
.
2017 Oct;22(10):823-824.
doi: 10.1111/nep.12823.
Authors
Andrea K Viecelli
1
2
,
Elaine M Pascoe
2
,
Kevan R Polkinghorne
3
4
5
,
Carmel M Hawley
1
2
,
Peta-Anne Paul-Brent
2
,
Sunil V Badve
2
6
7
,
Alan Cass
8
,
David W Johnson
1
2
,
Peter G Kerr
3
5
,
Trevor A Mori
9
,
Anish Scaria
2
,
Lai-Seong Hooi
10
,
Loke-Meng Ong
11
,
Ashley B Irish
9
12
;
FAVOURED study team
Affiliations
1
Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
2
Australasian Kidney Trials Network, School of Medicine, University of Queensland, Brisbane, Queensland, Australia.
3
Department of Nephrology, Monash Medical Centre, Melbourne, Victoria, Australia.
4
School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
5
Department of Medicine, Monash University, Melbourne, Victoria, Australia.
6
Department of Nephrology, St George Hospital, Sydney, New South Wales, Australia.
7
The George Institute for Global Health, Sydney, New South Wales, Australia.
8
Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.
9
School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia.
10
Department of Medicine and Haemodialysis Unit, Hospital Sultanah Aminah, Johor Bahru, Malaysia.
11
Department of Nephrology, Penang Hospital, George Town, Malaysia.
12
Department of Nephrology, Fiona Stanley Hospital, Perth, Western Australia, Australia.
PMID:
27188542
DOI:
10.1111/nep.12823
No abstract available
Publication types
Letter
Kommentar
MeSH terms
Arteriovenous Shunt, Surgical
Aspirin
Fatty Acids, Omega-3*
Fish Oils*
Humans
Kidney Diseases
Substances
Fatty Acids, Omega-3
Fish Oils
Aspirin